Rapid Micro Biosystems Files 8-K on Financials
Ticker: RPID · Form: 8-K · Filed: Jan 14, 2025 · CIK: 1380106
| Field | Detail |
|---|---|
| Company | Rapid Micro Biosystems, Inc. (RPID) |
| Form Type | 8-K |
| Filed Date | Jan 14, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: RMBS
TL;DR
RMBS filed an 8-K on Jan 14, 2025, updating on financials. Details TBD.
AI Summary
On January 14, 2025, Rapid Micro Biosystems, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, along with financial statements and exhibits. No specific financial figures or significant events were detailed in the provided excerpt.
Why It Matters
This filing provides an update on Rapid Micro Biosystems' financial performance and condition, which is crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- RAPID MICRO BIOSYSTEMS, INC. (company) — Registrant
- January 14, 2025 (date) — Date of report
- 25 Hartwell Avenue, Lexington, MA 02421 (address) — Principal executive offices
FAQ
What specific financial information is being reported in this 8-K?
The provided excerpt indicates the filing concerns 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but does not detail the specific financial figures.
When was this 8-K report filed?
The report was filed on January 14, 2025.
What is the principal business address of Rapid Micro Biosystems, Inc.?
The principal executive offices are located at 25 Hartwell Avenue, Lexington, MA 02421.
What is the SEC file number for Rapid Micro Biosystems, Inc.?
The SEC file number is 001-40592.
What is the SIC code for Rapid Micro Biosystems, Inc.?
The Standard Industrial Classification (SIC) code is 3826, for Laboratory Analytical Instruments.
Filing Stats: 535 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-01-14 16:17:51
Key Financial Figures
- $0.01 — which registered Class A Common Stock, $0.01 par value per share RPID The Nasdaq Cap
Filing Documents
- rpid-20250114.htm (8-K) — 28KB
- ex-991_prx20250114.htm (EX-99.1) — 17KB
- 0001380106-25-000009.txt ( ) — 208KB
- rpid-20250114.xsd (EX-101.SCH) — 2KB
- rpid-20250114_def.xml (EX-101.DEF) — 16KB
- rpid-20250114_lab.xml (EX-101.LAB) — 28KB
- rpid-20250114_pre.xml (EX-101.PRE) — 16KB
- rpid-20250114_htm.xml (XML) — 3KB
02
Item 2.02 Results of Operations and Financial Condition. On January 14, 2025, Rapid Micro Biosystems, Inc. (the "Company") issued a press release announcing its preliminary unaudited revenue results and certain business highlights for the fourth quarter and full year ended December 31, 2024. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference in its entirety. The information furnished under this Item 2.02, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as otherwise expressly stated in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release of Rapid Micro Biosystems, Inc. dated January 14, 2025 104 Cover Page Interactive Data File (formatted as inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. RAPID MICRO BIOSYSTEMS, INC. Date: January 14, 2025 By: /s/ Sean Wirtjes Sean Wirtjes Chief Financial Officer